Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Falkesgaard Højen, Jesper"'
Autor:
Yan, Xianglei, Ols, Sebastian, Arcoverde Cerveira, Rodrigo, Lenart, Klara, Hellgren, Fredrika, Ye, Kewei, Cagigi, Alberto, Buggert, Marcus, Nimmerjahn, Falk, Falkesgaard Højen, Jesper, Parera, Daniel, Pessara, Ulrich, Fischer, Stephan, Loré, Karin
Publikováno v:
Yan, X, Ols, S, Arcoverde Cerveira, R, Lenart, K, Hellgren, F, Ye, K, Cagigi, A, Buggert, M, Nimmerjahn, F, Falkesgaard Højen, J, Parera, D, Pessara, U, Fischer, S & Loré, K 2023, ' Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques ', Cellular and Molecular Life Sciences, vol. 80, no. 7, 189 . https://doi.org/10.1007/s00018-023-04828-2
Targeting CD40 by agonistic antibodies used as vaccine adjuvants or for cancer immunotherapy is a strategy to stimulate immune responses. The majority of studied agonistic anti-human CD40 antibodies require crosslinking of their Fc region to inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::4aadf5a50dbd189d49de1bbba0118157
https://pure.au.dk/portal/da/publications/cell-targeting-and-immunostimulatory-properties-of-a-novel-fcreceptorindependent-agonistic-anticd40-antibody-in-rhesus-macaques(8660a2f2-1024-491a-b816-4686055bb308).html
https://pure.au.dk/portal/da/publications/cell-targeting-and-immunostimulatory-properties-of-a-novel-fcreceptorindependent-agonistic-anticd40-antibody-in-rhesus-macaques(8660a2f2-1024-491a-b816-4686055bb308).html
Autor:
Jiang L; Department of Medicine, University of Colorado Denver, Aurora, CO, United States., Lunding LP; Division of Lung Immunology, Priority Area of Chronic Lung Diseases, Research Center Borstel-Leibniz Lung Center, Borstel, Germany.; Airway Research Center North, Member of the German Center for Lung Research (DZL), Giessen, Germany., Webber WS; Department of Medicine, University of Colorado Denver, Aurora, CO, United States., Beckmann K; MAB Discovery GmbH, Polling, Germany., Azam T; Department of Medicine, University of Colorado Denver, Aurora, CO, United States., Falkesgaard Højen J; Department of Medicine, University of Colorado Denver, Aurora, CO, United States.; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark., Amo-Aparicio J; Department of Medicine, University of Colorado Denver, Aurora, CO, United States., Dinarello A; Department of Medicine, University of Colorado Denver, Aurora, CO, United States., Nguyen TT; Mucosal Inflammation Program and Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Children's Hospital Colorado, University of Colorado, Aurora, CO, United States., Pessara U; MAB Discovery GmbH, Polling, Germany.; IcanoMAB GmbH, Polling, Germany., Parera D; MAB Discovery GmbH, Polling, Germany.; IcanoMAB GmbH, Polling, Germany., Orlicky DJ; Department of Pathology, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States., Fischer S; MAB Discovery GmbH, Polling, Germany.; IcanoMAB GmbH, Polling, Germany., Wegmann M; Division of Lung Immunology, Priority Area of Chronic Lung Diseases, Research Center Borstel-Leibniz Lung Center, Borstel, Germany.; Airway Research Center North, Member of the German Center for Lung Research (DZL), Giessen, Germany., Dinarello CA; Department of Medicine, University of Colorado Denver, Aurora, CO, United States., Li S; Department of Medicine, University of Colorado Denver, Aurora, CO, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jun 25; Vol. 15, pp. 1427100. Date of Electronic Publication: 2024 Jun 25 (Print Publication: 2024).
Autor:
Yan X; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden.; Center of Molecular Medicine, Stockholm, Sweden., Ols S; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden.; Center of Molecular Medicine, Stockholm, Sweden., Arcoverde Cerveira R; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden.; Center of Molecular Medicine, Stockholm, Sweden., Lenart K; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden.; Center of Molecular Medicine, Stockholm, Sweden., Hellgren F; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden.; Center of Molecular Medicine, Stockholm, Sweden., Ye K; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden.; Center of Molecular Medicine, Stockholm, Sweden., Cagigi A; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden.; Center of Molecular Medicine, Stockholm, Sweden., Buggert M; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden., Nimmerjahn F; Division of Genetics, Department of Biology, University of Erlangen-Nürnberg, Erlangen, Germany., Falkesgaard Højen J; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Medicine, University of Colorado Denver, Aurora, CO, USA., Parera D; Icano MAB GmbH, Polling, Germany., Pessara U; Icano MAB GmbH, Polling, Germany., Fischer S; Icano MAB GmbH, Polling, Germany., Loré K; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden. karin.lore@ki.se.; Center of Molecular Medicine, Stockholm, Sweden. karin.lore@ki.se.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2023 Jun 23; Vol. 80 (7), pp. 189. Date of Electronic Publication: 2023 Jun 23.